Moderna Inc yesterday said a Covid-19 booster designed to target the Beta variant as well as the original coronavirus generated a better immune response against a number of virus variants including Omicron.

Moderna said the results were a good sign for the company's plans for future shots targeting two Covid variants.

Dr Jacqueline Miller, a top Moderna scientist, said...